+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anatomic Pathology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5685022
This report on global anatomic pathology market studies various products and application prevalent in the market.According to the Centers for Disease Control and Prevention the budget for chronic disease prevention and health promotion for the financial year 2017 is US$1.1 Bn which is self-explanatory regarding the involvement of health regulatory authorities’ drive to promote health and awareness throughout the globe.The drivers of the anatomic pathology market are rising prevalence of critical illness, increasing inclination for a healthier lifestyle, rising demand for personalized medication and supportive reimbursement scenario.

For the purpose of this study, various productsof anatomic pathologystudied include instruments, consumables and services. The instruments segment is further categorized into tissue processing systems, slides staining system, microtomes and others; the consumables are sub-segmented as reagent and kits, antibodies and probes, whereas the services include cytopathology, histopathology and others. The application segment comprises of disease diagnosis, drug discovery and development, and others.Market size estimates and forecast for these segments for the period 2020 to 2030 are provided in terms of US$ Mn along with the respective CAGRs for the period 2022 to 2030, considering 2021 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global anatomic pathology market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global anatomic pathology market. The key players profiled in this report are Abbott Laboratories, Inc., Agilent Technologies, Inc., Boston Scientific Corporation, Danaher Corporation, F.Hoffman La Roche AG, Laboratory Corporation of America Holdings, Neogenomics Laboratories, Inc., Quest Diagnostics Incorporated, Sakura Finetechnical Co. Ltd., and Thermo Fisher Scientific, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Anatomic Pathology market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Anatomic Pathology market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Instruments
  • Tissue Processing Systems
  • Slides Staining Systems
  • Microtomes
  • Others
  • Consumables
  • Reagents And Kits
  • Antibodies
  • Probes
  • Services
  • Cytopathology
  • Histopathology
  • Others

Application

  • Disease Diagnosis
  • Drug Discovery and Development
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Anatomic Pathology market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Anatomic Pathology market?
  • Which is the largest regional market for Anatomic Pathology market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Anatomic Pathology market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Anatomic Pathology market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Anatomic Pathology Market
2.2. Global Anatomic Pathology Market, By Product, 2021 (US$ Million)
2.3. Global Anatomic Pathology Market, By Application, 2021 (US$ Million)
2.4. Global Anatomic Pathology Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Anatomic Pathology Market Vendors
2.7.2. Strategies Adopted by Anatomic Pathology Market Vendors
2.7.3. Key Industry Strategies
3. Anatomic Pathology Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Anatomic Pathology Market Value, 2020-2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Instruments
4.3.1.1. Tissue Processing Systems
4.3.1.2. Slides Staining Systems
4.3.1.3. Microtomes
4.3.1.4. Others
4.3.2. Consumables
4.3.2.1. Reagents And Kits
4.3.2.2. Antibodies
4.3.2.3. Probes
4.3.3. Services
4.3.3.1. Cytopathology
4.3.3.2. Histopathology
4.3.3.3. Others
5. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Disease Diagnosis
5.3.2. Drug Discovery and Development
5.3.3. Others
6. North America Anatomic Pathology Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
6.3. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
6.4.Anatomic Pathology Market: By Region, 2020-2030, USD (Million)
6.4.1.North America
6.4.1.1. U.S.
6.4.1.2. Canada
6.4.1.3. Rest of North America
7. UK and European Union Anatomic Pathology Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
7.3. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
7.4.Anatomic Pathology Market: By Region, 2020-2030, USD (Million)
7.4.1.UK and European Union
7.4.1.1. UK
7.4.1.2. Germany
7.4.1.3. Spain
7.4.1.4. Italy
7.4.1.5. France
7.4.1.6. Rest of Europe
8. Asia Pacific Anatomic Pathology Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
8.3. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
8.4.Anatomic Pathology Market: By Region, 2020-2030, USD (Million)
8.4.1.Asia Pacific
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Rest of Asia Pacific
9. Latin America Anatomic Pathology Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
9.3. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
9.4.Anatomic Pathology Market: By Region, 2020-2030, USD (Million)
9.4.1.Latin America
9.4.1.1. Brazil
9.4.1.2. Mexico
9.4.1.3. Rest of Latin America
10. Middle East and Africa Anatomic Pathology Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Anatomic Pathology Market: By Product, 2020-2030, USD (Million)
10.3. Anatomic Pathology Market: By Application, 2020-2030, USD (Million)
10.4.Anatomic Pathology Market: By Region, 2020-2030, USD (Million)
10.4.1.Middle East and Africa
10.4.1.1. GCC
10.4.1.2. Africa
10.4.1.3. Rest of Middle East and Africa
11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Agilent Technologies, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Boston Scientifc Corporation
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Danaher Corporation
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. F.Hoffman La Roche AG
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Laboratory Corporation of America Holdings
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. NeoGenomics Laboratories, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Quest Diagnostics Incorporated
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Sakura Finetechnical Co., Ltd.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Thermo Fisher Scientific, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
List of Figures
Figure 1 Global Anatomic Pathology Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Anatomic Pathology Market: Quality Assurance
Figure 5 Global Anatomic Pathology Market, By Product, 2021
Figure 6 Global Anatomic Pathology Market, By Application, 2021
Figure 7 Global Anatomic Pathology Market, By Geography, 2021
Figure 8 Global Anatomic Pathology Market, By Product, 2021 Vs 2030, %
Figure 9 Global Anatomic Pathology Market, By Application, 2021 Vs 2030, %
Figure 10 U.S. Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 11 Canada Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 12 Rest of North America Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 13 UK Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 14 Germany Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 15 Spain Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 16 Italy Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 17 France Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 18 Rest of Europe Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 19 China Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 20 Japan Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 21 India Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 22 Australia Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 23 South Korea Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 24 Rest of Asia Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 25 Brazil Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 26 Mexico Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 27 Rest of Latin America Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 28 GCC Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 29 Africa Anatomic Pathology Market (US$ Million), 2020 - 2030
Figure 30 Rest of Middle East and Africa Anatomic Pathology Market (US$ Million), 2020 - 2030

Companies Mentioned

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Boston Scientifc Corporation
  • Danaher Corporation
  • F.Hoffman La Roche AG
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories Inc.
  • Quest Diagnostics Incorporated
  • Sakura Finet